|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/14 | |
| A61K 47/60 | |||
| A61K 31/5025 | |||
| A61K 47/69 | |||
| A61K 9/51 |
| (11) | Number of the document | 2968153 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14722412.5 |
| Date of filing the European patent application | 2014-03-12 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/023922 |
| Date | 2014-03-12 |
| (87) | Number | WO 2014/164957 |
| Date | 2014-10-09 |
| (30) | Number | Date | Country code |
| 201361776964 P | 2013-03-12 | US |
| (72) |
BROWN, Peter, D., US
DRAGER, Anthony, S., US
|
| (73) |
Cephalon, Inc.,
41 Moores Road P.O. Box 4011, Frazer, PA 19355,
US
|
| (54) | NANOPARTICULATE AND MACROPARTICULATE FORMULATIONS |
| NANOPARTICULATE AND MACROPARTICULATE FORMULATIONS |